Homepage
FRESH Analysis Report
Jun 9, 2026
3 days ago · 96% complete · +5 refreshed

Nextpower Inc.

NXT NASDAQ Categories PDF
Technology · Consumer Electronics
Fremont, CA 94555, United States IPO 2023 nextpower.com Updated Jun 12, 4:52am
Price
$119.68
Market Cap
$18.0B
Employees
1,300
Beta
1.74
Avg Volume
2,284,555
CEO
Daniel S. Shugar
Business Description

Nextracker Inc. is an energy solutions provider specializing in solar tracking systems for photovoltaic (PV) installations. Their product lineup encompasses a variety of solar trackers, such as Bifacial PV modules tailored for extensive solar farms, the NX Horizon for typical solar power plants, and the NX Gemini, a two-in-portrait tracker designed to maximize the long-term value and operational efficiency for both project developers and asset owners. Additionally, they offer the NX Horizon XTR, a robust all-terrain solar tracker. Complementing their hardware, Nextracker provides advanced software solutions, including TrueCapture, an intelligent, adaptive control system for optimizing PV power plant performance, and NX Navigator, software for operational oversight and risk management. Established in 2013, the company is headquartered in Fremont, California, and operates as a subsidiary of Flex Ltd.

Business History
Generated: Jun 9, 2026 6:37pm
Price Overview
Last updated: Jun 13, 2026 12:06am (just now)
$121.88
+2.20 (+1.84%)
Day Range
$120.66 – $127.97
52-Week Range
$51.69 – $163.13
50-Day MA
$124.27
200-Day MA
$102.82
Volume
2,456,514.00
Analyst Price Targets
Low $125.00
Consensus $151.61
High $180.00
(77 analysts)
Share Structure
Outstanding 150,274,472.00
Float 147,860,320.00
Free Float 98.4%
High free float — 98.4% of shares trade freely, ~1.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jun 13, 2026 12:06am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 9, 2026 7:36pm (3d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
30.89
Stock Price: $119.68
EPS (Diluted): 3.96
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
7.64
Stock Price: $119.68
Total Equity: $2.33B
Shares: 152,710,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
23.82
Market Cap: $17.98B
Total Debt: $0.00
Cash: $1.09B
EBITDA: $727.87M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$16.7B
Market Cap: $17.98B
Total Debt: $0.00
Cash: $1.09B
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
32.6%
Gross Profit: $1.16B
Revenue: $3.56B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
19.6%
Operating Income: $697.27M
Revenue: $3.56B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
16.5%
Net Income: $585.88M
Revenue: $3.56B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
28.3%
Net Income: $585.88M
Total Equity: $2.33B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
19.8%
Operating Income: $697.27M
Tax Rate: 17.9%
Equity: $2.33B
Total Debt: $0.00
Cash: $1.09B
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
2.45
Current Assets: $2.85B
Current Liabilities: $1.16B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $2.33B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$23.31
Revenue: $3.56B
Shares: 152,710,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$15.29
Total Equity: $2.33B
Shares: 152,710,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$3.35
Operating CF: $556.45M
CapEx: -$44.81M
Shares: 152,710,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $119.68
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $585.88M
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 9, 2026 6:37pm
Compares NXT against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis
Last run: Jun 9, 2026 6:40:50 pm

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for Mature Earner companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for Mature Earner companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for Mature Earner companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for Mature Earner companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for Mature Earner companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for Mature Earner companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 9, 2026 7:36pm (3d ago)
Metric 2022 2023 2024 2025 2026
Revenue $1.5B $1.9B $2.5B $3.0B $3.6B
Cost of Revenue $1.3B $1.6B $1.8B $2.0B $2.4B
Gross Profit $147.0M $287.0M $691.6M $998.2M $1.2B
Operating Expenses $81.1M $118.5M $104.5M $359.1M $462.8M
Operating Income $65.9M $168.5M $587.1M $639.1M $697.3M
Net Income $50.9M $118.9M $306.2M $509.2M $585.9M
EBITDA $90.0M $174.6M $591.5M $652.5M $727.9M
EPS $1.11 $0.02 $3.97 $3.55 $3.96
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 9, 2026 6:35pm (3d ago)
Metric 2022 2023 2024 2025 2026
Cash & Equivalents $29.1M $130.0M $474.1M $766.1M $1.1B
Total Current Assets $708.8M $872.3M $1.8B $2.2B $2.8B
Total Assets $1.0B $1.4B $2.5B $3.2B $4.1B
Current Liabilities $473.4M $507.4M $891.5M $1.0B $1.2B
Long-Term Debt $0 $147.1M $144.0M $0 $0
Total Liabilities $516.2M $934.8M $1.5B $1.6B $1.7B
Total Equity $501.1M -$3.1B $961.0M $1.6B $2.3B
Retained Earnings -$3.0M -$3.1B -$3.1B -$2.6B $0
Cash Flow (Annual)
Last updated: Jun 9, 2026 7:36pm (3d ago)
Metric 2022 2023 2024 2025 2026
Operating Cash Flow -$147.1M $107.7M $429.0M $655.8M $556.5M
Capital Expenditure -$5.9M -$3.2M -$6.7M -$33.9M -$44.8M
Free Cash Flow -$153.0M $104.5M $422.3M $621.9M $511.6M
Acquisitions (net) $167,000 $24,000 $0 -$152.2M -$117.2M
Debt Repayment
Dividends Paid
Stock Buybacks $0 -$693.8M -$552.0M $0 $-395,000
Net Change in Cash -$161.5M $100.9M $344.0M $292.0M $328.9M
Analyst Estimates (Annual)
Last updated: Jun 12, 2026 4:52am (19h ago)
Metric 2028 2029 2030 2031
Revenue $4.8B
$4.6B – $4.9B
$5.4B
$5.1B – $5.6B
$6.2B
$5.8B – $6.6B
$6.8B
$6.4B – $7.2B
EBITDA $1.8B
$1.7B – $1.9B
$2.0B
$1.9B – $2.1B
$2.3B
$2.2B – $2.5B
$2.6B
$2.4B – $2.7B
Net Income $904.0M
$809.0M – $999.1M
$910.4M
$826.6M – $1.3B
$1.2B
$1.1B – $1.3B
$1.4B
$1.3B – $1.5B
EPS
Growth Trends (YoY %)
Last updated: Jun 9, 2026 7:36pm (3d ago)
Metric 2023 2024 2025 2026
Revenue Growth +30.5% +31.4% +18.4% +20.3%
Gross Profit Growth +95.2% +141.0% +44.3% +16.2%
Operating Income Growth +155.6% +248.5% +8.9% +9.1%
Net Income Growth +133.5% +157.6% +66.3% +15.1%
EBITDA Growth +94.0% +238.9% +10.3% +11.5%
Insider Trading (Recent)
Last updated: Jun 12, 2026 10:57pm (1h ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-05 SHUGAR DANIEL S J-Other 21,402.00 $144.73 $3.1M
2026-06-04 SHUGAR DANIEL S M-Exempt 21,402.00 $21.00 $449,442
2026-06-04 SHUGAR DANIEL S M-Exempt 21,402.00 $21.00 $449,442
2026-06-01 BOYNTON CHARLES D S-Sale 4,500.00 $151.79 $683,055
2026-05-29 SHUGAR DANIEL S M-Exempt 55,000.00 $21.00 $1.2M
2026-06-01 SHUGAR DANIEL S J-Other 7,435.00 $142.45 $1.1M
2026-06-01 SHUGAR DANIEL S J-Other 10,502.00 $143.13 $1.5M
2026-06-01 SHUGAR DANIEL S J-Other 10,067.00 $144.28 $1.5M
2026-06-01 SHUGAR DANIEL S J-Other 11,598.00 $145.44 $1.7M
2026-06-01 SHUGAR DANIEL S J-Other 7,131.00 $146.19 $1.0M
2026-06-01 SHUGAR DANIEL S J-Other 3,807.00 $147.33 $560,885
2026-06-01 SHUGAR DANIEL S J-Other 1,500.00 $148.19 $222,285
2026-06-01 SHUGAR DANIEL S J-Other 700.00 $149.36 $104,552
2026-06-01 SHUGAR DANIEL S J-Other 1,360.00 $150.67 $204,911
2026-06-01 SHUGAR DANIEL S J-Other 700.00 $151.47 $106,029
2026-06-01 SHUGAR DANIEL S J-Other 200.00 $152.09 $30,418
2026-05-29 SHUGAR DANIEL S M-Exempt 55,000.00 $21.00 $1.2M
2026-05-29 Miller Nicholas Marco S-Sale 22,427.00 $156.00 $3.5M
2026-05-26 SHUGAR DANIEL S M-Exempt 55,000.00 $21.00 $1.2M
2026-05-27 SHUGAR DANIEL S J-Other 1,714.00 $129.01 $221,123
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for NXT.
Delvantic AI Findings
Independent analyst synthesis · Delvantic - Cairn AI · generated 2026-06-09 18:41:26
Reviews the pipeline's own verdicts
Verdict Overvalued on a stalled topline — fair value $75–80 vs. $119 spot; revenue has been flat for 4 quarters and insiders are distributing, wait for sub-$90 or two quarters of reaccelerating growth.

Looking at the raw quarterly tape first: revenue went $924M → $864M → $905M → $909M → $880M over the last five quarters. That's not growth — that's a plateau, with the most recent print down 4.7% sequentially and down 4.7% YoY against the $924M Q1'25 comp. The trailing four quarters sum to ~$3.56B (matches the FY figure), but the run-rate has stalled around $3.5–3.6B for a full year now. Meanwhile the prior models are anchoring on the 19.3% revenue CAGR and 20.3% "recent YoY" — those are arithmetic artifacts of the FY26 vs FY25 comparison where the back half of FY25 had weak $635M/$679M quarters. The forward setup is much worse than the trailing optics suggest. Net income margins are healthy (14–18%) and FCF is real ($512M), but earnings YoY of 15% already lags revenue growth optics and is decelerating from a 38% CAGR base.

On the synthesis and market-forces verdicts: I largely agree with the "Neutral / High Conviction Required" framing but think both layers undersell the deceleration. The pre-flight call that this is "rapidly scaling" is stale — scaling stopped four quarters ago. The narrative layer's "platform-monopoly / anchored" tag is generous; Nextracker's software attach (TrueCapture/Navigator) is a small fraction of revenue and the hardware business is a steel-and-actuators commodity exposed to project-developer capex cycles. The 32.6% gross margin is impressive versus the 15% GM they printed in FY22, but margin expansion of that magnitude (10x op income in four years from $66M to $697M) is exactly the kind of mean-reversion candidate a contrarian should flag. ROIC of 19.8% is good but not platform-monopoly good, and the absence of disclosed total debt/equity in the file is a gap I'd want filled before underwriting the 7.6x P/B.

The contrarian read writes itself: you're paying 30x TTM earnings and ~5x sales for a company whose revenue has been flat-to-down for a year, whose end-market (US utility-scale solar) faces real IRA/ITC policy risk under the current administration, and whose insiders printed 10+ disposition-flavored transactions in a single week in early June 2026 (M-Exempt + J-Other + S-Sale clustering is classic option-exercise-and-sell behavior, not conviction buying). The bull case requires either (a) a reacceleration to 15%+ growth in FY27 — for which the quarterly trajectory gives zero evidence — or (b) sustained 17%+ net margins through a potential solar capex air pocket. Neither is the base case. Reverse-DCF embedded 52% FCF growth (per thesis eval) is laughable against 10.1% trailing FCF CAGR and a stalled topline.

Where the models are wrong: the rule-based "mature_earner" tag is actually closer to right than the pre-flight "high-growth-industrial" tag — the numbers say mature, not growing. I dissent from the implicit "hold and wait" posture of the synthesis. At $119 and $17.9B market cap, fair value on a normalized $550–600M FCF base at a 20x multiple (appropriate for a cyclical industrial leader with policy risk, not a platform) is closer to $11–12B, or **$75–80 per share**. You're paying a 50% premium for a narrative that the tape is actively contradicting. The right move is to wait for either a sub-$90 entry or two consecutive quarters of reaccelerating revenue with stable margins — whichever comes first. Insider selling plus revenue plateau plus policy overhang plus 30x earnings is not a setup that rewards patience at this price.

GPT Critique
Second-opinion review · gpt-4o · generated 2026-06-09 18:41:30
Reviews the Opus findings above
Verdict I agree with Opus — overvalued at $119, with fair value closer to $75–80 as revenue growth stalls and insider selling raises caution.

In examining Nextpower Inc.'s financial data, several points stand out that shape my independent analysis. The company's revenue has indeed plateaued, fluctuating around $880M to $909M over the last five quarters, indicating a halt in growth momentum. This stagnation is concerning, especially given the high expectations set by a previous annual revenue CAGR of 19.3%. The net income margins remain respectable, ranging from 14% to 18%, but the recent sequential revenue decline of 4.7% is a red flag. Moreover, the company's robust free cash flow of $511.6M and a solid cash position of $1.09B provide a cushion, yet they do not justify the current valuation considering the growth deceleration. The company's impressive gross margin of 32.6% from a mere 15% in FY22 suggests substantial efficiency gains, yet such rapid improvements often invite skepticism about sustainability.

I align with Claude Opus's assessment that Nextpower Inc. is overvalued under current conditions. Opus rightly identifies the core issue: a stalled revenue trajectory contradicting the narrative of high growth. The suggested fair value range of $75–80 seems appropriate given the revenue stagnation and insider selling activity, which signals potential lack of confidence among those closest to the company. I also concur with Opus's skepticism regarding the narrative of a "platform-monopoly" given the hardware business's exposure to commoditization and capex cycles. The market's expectation of sustained growth and margin expansion appears overly optimistic.

However, I diverge from Opus on the magnitude of the insider selling issue. While Opus interprets the insider transactions as a significant negative signal, the lack of detailed context regarding these transactions (e.g., whether they are part of routine sales plans) tempers my concern slightly. These sales, though not ideal, could be less alarming if they are part of scheduled diversification by insiders, though this is speculative without further data.

A skeptic of both analyses might argue that the company's cash flow strength and margin improvements position it well to capitalize on any resurgence in solar infrastructure investments, potentially justifying a premium valuation. They might also highlight that the current market environment could facilitate strategic acquisitions or expansions, leveraging their cash reserves. Despite these points, the fundamental issues of revenue stagnation and policy risks remain pressing concerns that outweigh speculative positives.

Advanced Analysis Forensic deep-dive · two lenses
Two separate reads — Company Quality (is it a great business?) and Valuation (is it mispriced?), kept deliberately apart · 2026-06-09 18:42:56
Delvantic - Cairn AI
Quality name — wait for a dip 7/10
Strong business (+29 quality) trading right on top of fair value (-53 value) — admire it, don't chase it; my bid is sub-$95.
The cruxWhether the software/recurring attach (TrueCapture, NX Navigator) proves sticky enough to justify paying a growth-software multiple for what is still cyclical tracker hardware.
Company Quality
+29
Strong
edge √Σ 123 · risk √Σ 94 · conf 7/10
Valuation / Mispricing
-53
Fairly Valued
edge √Σ 30 · risk √Σ 83 · conf 5/10
Liquidity & RunwaySelf-Funding
DilutionHeavy Dilution
Earnings QualityAdequate / Mixed
The Play — combined read across both lenses Delvantic - Cairn AI

The two lenses tell a clean story: Lens 1 at +29 says this is a genuinely good operating business — tripled gross margin, $1.1B net cash, FCF positive, ongoing dilution benign once you strip the IPO optical artifact. Lens 2 at -53 says the market already knows. At $119 against a deserved $110–$125 band, there is no margin of safety, and the OCF/NI 0.33x plus 'High Conviction Required' from the e2e tells me the deserved multiple should be trimmed, not stretched. Great company + fair price = watchlist, not position. I'm not paying a software multiple for hardware-weighted revenue until software attach is proven.

Playbook: zero position today. I set a starter bid at $95 (~20% lower, the value lens's attractive-below line) for roughly 1.5% of the book, and I scale to a full ~4% position only if it trades into the $80s on a capex-cycle scare WITHOUT the quality thesis breaking (margins holding, FCF still positive, net cash intact). Above $95 I only get involved if management delivers hard evidence of recurring software revenue scaling — that flips the deserved multiple up and I'd pay current prices for a starter. Catalysts that send me to the sidelines entirely: OCF/NI staying below 0.5x for another year, operating margin continuing to roll (it's already slipped from 23.5% to 19.6%), or insider selling accelerating beyond programmatic. This is a 'be patient and get paid for the patience' setup, not a 'great business, just buy it' setup.

The evidence behind each score — switch lenses
+29 Strong edge √Σ 123 · risk √Σ 94 · conf 7/10

The operating business is firing: revenue went from $1.46B (2022) to $3.56B (2026), gross margin expanded from 10.1% to 32.6%, operating margin from 4.5% to ~20%, and net income from $50.9M to $585.9M. FCF turned from -$153M to +$511.6M, and the balance sheet shows $1.09B net cash with an Altman Z of 8.12 — survival is not a question. This is a real operating leverage story (likely solar tracker hardware given Shugar/Nextracker DNA), with structurally improving unit economics rather than financial engineering.

The quality blemishes are non-trivial. Diluted shares went from 45.9M (2022) to 152.7M (2026) — a 35.1% CAGR. Even allowing for an IPO-related step-up between 2022 and 2023 (45.9M→145.9M is almost certainly the float coming online, not pure dilution), the 2023→2026 drift from 145.9M to 152.7M is still ~1.5%/yr of ongoing dilution, modest but real. More worrying for earnings integrity: OCF/NI is only 0.33x and accruals are 2.3% of assets in the latest period — reported earnings are running well ahead of cash conversion even as FCF remains positive in absolute dollars. Beneish M (-2.92) does not flag manipulation, but the cash-vs-accrual gap deserves scrutiny.

Insider behavior is mixed-to-negative: 12 sells / 0 buys over 12 months ($22.6M sold), with the CEO (Shugar) running a heavy disposition pattern in early June 2026. Most are M-exempt option exercises paired with J-other dispositions (likely a 10b5-1 or planned program tied to vesting), not panic selling — but the complete absence of open-market buying alongside an unusual selling cadence is a yellow flag, not a green one.

Strengths 3
m85
Exceptional margin expansion with revenue growth
Gross margin tripled from 10.1% to 32.6% and operating margin went from 4.5% to ~20% while revenue grew from $1.46B to $3.56B (24% CAGR). That combination — scale plus structural margin gain — is the signature of a business with real operating leverage and likely pricing power.
m70
Fortress balance sheet, self-funding
$1.09B net cash, Altman Z of 8.12, and $511.6M annual FCF. No reliance on capital markets to fund the business; the company can weather a demand air pocket without distress.
m55
Buyback materially exceeds SBC
Buyback/SBC ratio of 591% with SBC at ~0% of revenue indicates management is actually retiring shares, not just offsetting comp dilution — a positive capital-allocation signal once the IPO-related share count normalizes.
Concerns 4
m65
OCF/NI of 0.33x — earnings outrunning cash
Net income of $585.9M but OCF/NI at only 0.33x and accruals at 2.3% of assets means reported profitability is materially ahead of cash generation. FCF of $511.6M is still healthy in absolute terms, but the gap warrants checking working-capital build (receivables, contract assets) — a known risk in long-cycle hardware/project businesses.
m50
Insider selling with zero buying
12 sells, 0 buys, $22.6M disposed in 12 months. CEO Shugar's June 2026 cluster is largely option-exercise-and-sell (M-exempt + J-other), which is programmatic, but the complete absence of open-market accumulation alongside an 'unusual' cadence flag is not a vote of confidence.
m35
Headline 35% diluted-share CAGR overstates ongoing dilution
Share count jumped 45.9M→145.9M in 2022→2023 (likely IPO-driven float emergence, not operational dilution), then drifted to 152.7M by 2026 — a more modest ~1.5%/yr from a normalized base. The reported 35.1% CAGR is mechanically real but largely a one-time recapitalization artifact.
m30
Operating margin rolled over slightly
OpM peaked at 23.5% in 2024 and slipped to 21.6% (2025) and 19.6% (2026). Modest, but the trajectory is no longer uniformly up — bears watching as the business scales further.
This is a high-quality operating business that I'd put a notch below fortress. The economic engine is genuinely impressive — you don't accidentally triple gross margin while doubling revenue, and the balance sheet is clean with real cash generation. The 35% dilution headline scared me until I looked at the year-by-year and it's almost entirely an IPO-window optical artifact; ongoing dilution is benign and buybacks outpace SBC meaningfully. What keeps me from grading higher is the OCF/NI ratio of 0.33x — earnings are running materially ahead of cash, which in a hardware/project business is the classic spot where future write-downs hide. Pair that with insiders cashing out and never buying, and a small but real margin rollover, and I land at Strong-but-watch-the-cash-conversion rather than unambiguously elite.
Verify before trusting this (7)
  • Working-capital roll: are receivables, unbilled revenue, or contract assets growing faster than revenue and driving the OCF/NI gap?
  • Customer concentration — solar tracker/utility-scale hardware businesses often have top-3 customers >30% of revenue
  • Backlog and revenue visibility disclosures — durability of the 20%+ growth profile
  • Detail on the 2022→2023 share count jump (IPO mechanics vs. true issuance) to confirm ongoing dilution is in fact ~1-2%/yr, not 35%
  • Whether Shugar's June 2026 sales were under a Rule 10b5-1 plan and whether retained ownership remains meaningful
  • Tariff/IRA exposure and supply-chain concentration risk for a likely China/SE-Asia-sourced hardware product
  • Margin sustainability: is the gross margin expansion from mix, pricing, or a temporary supply/demand imbalance?
-53 Fairly Valued edge √Σ 30 · risk √Σ 83 · conf 5/10
Price $119 vs deserved ~$110–$125 range — essentially fair, no margin of safety either direction. attractive below $95.00

Nextracker at $119.27 carries a ~$17.9B market cap on a business the quality lens calls Strong but a notch below fortress, with OCF lagging NI and meaningful (even if IPO-optical) dilution. The e2e synthesis flagged 'High Conviction Required' rather than handing back a clean fair-value anchor, which is itself a tell — the methods aren't converging cleanly, and on a cyclical hardware-led business with unproven software stickiness, that ambiguity should compress, not expand, the deserved multiple. Earnings quality is rated Adequate/Mixed, which warrants a modest haircut to whatever DCF/multiple output you're tempted to lean on.

The bull case (platform monopoly, recurring TrueCapture/NX Navigator software, secular solar capex) is real but is exactly what the current multiple already pays for. The bear case (tracker hardware commoditization, capex-cycle sensitivity, software attach unproven at scale) means the deserved multiple should sit below where pure-software comps trade. Net: deserved value is plausibly in a wide $100–$135 band around today's price. That's a coin flip, not an opportunity.

I'd want a clear discount — closer to $95 — before treating this as a valuation buy, and I'd start trimming above ~$145 where the price demands heroic software-attach assumptions.

Cheap signals 1
m30
Strong operating trajectory supports a premium
Revenue 2.4x with gross margin tripling is a genuine quality signal that raises deserved value vs. peers — just not enough to call $119 a discount.
Rich / priced-in 4
m55
Platform-monopoly narrative already in the multiple
At $17.9B market cap the stock is priced as if software stickiness and tracker dominance are durable givens, but the bear case on hardware commoditization and unproven software attach is not yet disproven.
m45
Earnings-quality haircut warranted
OCF lagging NI plus 'Adequate/Mixed' earnings quality means whatever DCF fair value the e2e produced deserves a 10–15% trim before comparison to price.
m35
Cyclical capex exposure not multiple-friendly
Tracker demand follows developer capex cycles; paying a growth-software-like multiple for a hardware-weighted revenue mix overstates deserved value.
m25
e2e flagged 'High Conviction Required'
When methods don't converge on a cyclical business, the honest read is no margin of safety — not an excuse to lean on the highest fair-value output.
Fairly valued at $119 — I'm not a buyer here and I'm not a seller. The business is good, the quality lens already said so, but good businesses at fair prices are not edge. I need this ~20% lower (sub-$95) before the platform-monopoly story gives me actual margin of safety, or I need clean evidence software attach is sticky enough to justify paying the current multiple. Until one of those shows up, this is a watch-list name, not a position.
Verify before trusting this (5)
  • Forward guidance on backlog conversion and 2025/2026 revenue cadence — confirms or denies the cyclical-peak fear
  • Software revenue mix and attach rate disclosures (TrueCapture, NX Navigator) — the entire premium hinges on this
  • Gross margin sustainability vs. recent peak — is the tripling structural or a steel/logistics tailwind?
  • Ongoing (ex-IPO-optical) dilution run-rate from SBC
  • Customer concentration and project-developer capex commentary
Two lenses kept deliberately separate — Company Quality is price-agnostic; Valuation is price-conditional. The scores are not blended (yet). Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Community AI Feedback
No community reviews yet for NXT. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.330 · 344c2a54 · 2026-06-09 20:20:16